Position in INSM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$20,924,494
New position
Shares Held
196,253
first reported quarter
Ownership
0.090%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#118
of 663 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $177,836,332 across 11 Biotechnology names. INSM ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
57,903 | $53,720,666 | |
| 2 | ASND |
Ascendis Pharma A/S
|
141,010 | $37,610,187 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,893 | $24,286,619 | |
| 4 | INSM |
INSMED Inc
This page
|
196,253 | $20,924,494 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21,035 | $13,116,163 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,492 | $10,383,126 | |
| 7 | RPRX |
Royalty Pharma plc
|
136,346 | $7,644,920 | |
| 8 | BNTX |
BioNTech SE
|
51,109 | $4,755,692 |
All Filings in INSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,924,494 | 196,253 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||